'Dyschromia in confetti' as a side effect of topical immunotherapy with diphenylcyclopropenone.

'Dyschromia in confetti' as a side effect of topical immunotherapy with diphenylcyclopropenone. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

'Dyschromia in confetti' as a side effect of topical immunotherapy with diphenylcyclopropenone. Abstract Text:

"Dyschromia in confetti" is a pigmentary disturbance that so far has not been reported to have occurred during topical immunotherapy. In a group of 243 patients treated with diphenylcyclopropenone for alopecia areata, four patients showed a similar pattern of hyperpigmentation and hypopigmentation. In one patient the pigmentary disturbance was confined to the site of diphenylcyclopropenone application on the scalp. Besides dyschromic skin changes on her scalp, one patient had development of a hyperpigmentation on her forearms. In the remaining two patients, dyschromia in confetti became manifest exclusively in areas other than the scalp. This type of pigmentary disturbance appeared 4 to 14 months after the start of treatment, and it has remained unchanged in three patients during a follow-up period of 3 to 10 months. In one patient, the pigmentary changes disappeared when therapy was discontinued but recurred, albeit to a lesser extent, after treatment had been resumed. We conclude that dyschromia in confetti should be regarded as a possible, but probably rare, side effect of topical immunotherapy with diphenylcyclopropenone, especially in individuals with a rather dark complexion.

'Dyschromia in confetti' as a side effect of topical immunotherapy with diphenylcyclopropenone. Publishing Authors By Initials

For similar skin and connective tissue diseases: skin diseases: pigmentation disorders research abstracts see: skin and connective tissue diseases: skin diseases: pigmentation disorders research

PUBMED ID PMID:

MEDLINE DATE:

'Dyschromia in confetti' as a side effect of topical immunotherapy with diphenylcyclopropenone. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Archives of dermatology

VOLUME: 128

Page Numbers: 518-20

Journal Abbreviation: Arch Dermatol

ISSN: 0003-987X

DAY: 17

MONTH: Apr

YEAR: 1992

'Dyschromia in confetti' as a side effect of topical immunotherapy with diphenylcyclopropenone. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 372433

'Dyschromia in confetti' as a side effect of topical immunotherapy with diphenylcyclopropenone. Keywords Mesh Terms:

KEYWORDS: Pigmentation Disorders

MESH TERMS: chemically induced

Chemical & Substance for Abstract: 'Dyschromia in confetti' as a side effect of topical immunotherapy with diphenylcyclopropenone. Information

Substance Name: diphenylcyclopropenone

Registry Number: 886-38-4

Grant and Affiliation Information for 'Dyschromia in confetti' as a side effect of topical immunotherapy with diphenylcyclopropenone.

AFFILIATION: Department of Dermatology, University of Nijmegen, The Netherlands.

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Arch Dermatol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

'Dyschromia in confetti' as a side effect of topical immunotherapy with diphenylcyclopropenone Related Publications

• 'Dyschromia in confetti' as a side effect of topical immunotherapy with diphenylcyclopropenone.
• A fresh look at incontinentia pigmenti.
• A rule concerning the segmental manifestation of autosomal dominant skin disorders. Review of clinical examples providing evidence for dichotomous types of severity.
• Acne of the fulminans type following testosterone therapy in three excessively tall boys.
• An epidermal nevus syndrome with cerebral involvement caused by a mosaic FGFR3 mutation.
• Axillary apocrine chromhidrosis.
• Cutis tricolor coexistent with cutis marmorata telangiectatica congenita: "phacomatosis achromico-melano-marmorata".
• Dermabrasion for the treatment of xeroderma pigmentosum.
• Diphencyprone for the treatment of alopecia areata: more data and new aspects.
• Etretinate in the treatment of juvenile pityriasis rubra pilaris.
• Hypomorphic alleles within the EBP gene cause a phenotype quite different from Conradi-Hünermann-Happle syndrome.
• LOH-pitfalls of an ambiguous abbreviation.
• Letter: Neurofibroma and nevoid basal cell carcinoma.
• Mosaicism in human skin. Understanding the patterns and mechanisms.
• Paraproteinaemia in erythema elevatum diutinum.
• Phacomatosis Pigmentokeratotica: A Follow-up Report Documenting Additional Cutaneous and Extracutaneous Anomalies.
• Phacomatosis cesioflammea with unilateral lipohypoplasia.
• Phacomatosis pigmentokeratotica: report of new cases and further delineation of the syndrome.
• Phacomatosis spilorosea associated with lymphoedema.
• Segmental lesions are not always agminated.
• Skin markers of X-linked dominant chondrodysplasia punctata.
• The essence of alternative medicine. A dermatologist's view from Germany.
• The manifold faces of proteus syndrome.
• The potential hazards of dinitrochlorobenzene.
• What every dermatologist should know about homeopathy.
• What is IFAP syndrome?
• [Becker nevus syndrome.]